Anastasia Constantinidou

Summary

Country: UK

Publications

  1. doi request reprint Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit
    Anastasia Constantinidou
    Melanoma Unit, Guy s and St Thomas Foundation NHS Trust, London, UK
    Melanoma Res 18:56-60. 2008
  2. doi request reprint Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
    Anastasia Constantinidou
    Sarcoma Unit, Royal Marsden Hospital, Fulham Rd, London SW3 6JJ, UK
    Eur J Cancer 45:2930-4. 2009
  3. ncbi request reprint Informational needs of patients with melanoma and their views on the utility of investigative tests
    A Constantinidou
    Melanoma Group, Guy s and St Thomas NHS Foundation Trust, London SW156NP, UK
    Int J Clin Pract 63:1595-600. 2009
  4. doi request reprint Role of palliative chemotherapy in advanced epithelioid sarcoma
    Robin L Jones
    Sarcoma Unit, Royal Marsden Hospital, London, UK
    Am J Clin Oncol 35:351-7. 2012
  5. doi request reprint Advanced aggressive fibromatosis: Effective palliation with chemotherapy
    Anastasia Constantinidou
    Sarcoma Unit, Royal Marsden Hospital, London, United Kingdom
    Acta Oncol 50:455-61. 2011
  6. doi request reprint The evolution of systemic therapy in sarcoma
    Anastasia Constantinidou
    The Royal Marsden Hospital, London, UK
    Expert Rev Anticancer Ther 13:211-23. 2013
  7. ncbi request reprint Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection
    Anastasia Constantinidou
    Department of Medicine, Royal Marsden Hospital, London and Surrey, UK
    Clin Colorectal Cancer 12:15-22. 2013
  8. doi request reprint Chemotherapy in clear cell sarcoma
    Robin L Jones
    Royal Marsden Hospital, London, UK
    Med Oncol 28:859-63. 2011
  9. doi request reprint Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?
    Anastasia Constantinidou
    Breast Unit, Royal Marsden Hospital, London UK and Institute of Cancer Research, London, UK
    Breast 20:S158-61. 2011
  10. ncbi request reprint Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience
    Michael S Hofman
    PET Imaging Centre at St Thomas, Guy s and St Thomas Foundation NHS Trust, and King s College, London, UK
    Nucl Med Commun 28:902-6. 2007

Detail Information

Publications11

  1. doi request reprint Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit
    Anastasia Constantinidou
    Melanoma Unit, Guy s and St Thomas Foundation NHS Trust, London, UK
    Melanoma Res 18:56-60. 2008
    ..It is questionable whether any imaging is beneficial at this stage. The results of this review suggest that PET scanning might not be indicated for this group of patients...
  2. doi request reprint Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
    Anastasia Constantinidou
    Sarcoma Unit, Royal Marsden Hospital, Fulham Rd, London SW3 6JJ, UK
    Eur J Cancer 45:2930-4. 2009
    ..Recent reports indicate that pegylated liposomal doxorubicin (PLD) is effective...
  3. ncbi request reprint Informational needs of patients with melanoma and their views on the utility of investigative tests
    A Constantinidou
    Melanoma Group, Guy s and St Thomas NHS Foundation Trust, London SW156NP, UK
    Int J Clin Pract 63:1595-600. 2009
    ..The aim of the study was to identify the informational needs of patients with melanoma on disease status and prognosis, and to ascertain their views on the utility of positron emission tomography (PET) and sentinel node biopsy (SNB)...
  4. doi request reprint Role of palliative chemotherapy in advanced epithelioid sarcoma
    Robin L Jones
    Sarcoma Unit, Royal Marsden Hospital, London, UK
    Am J Clin Oncol 35:351-7. 2012
    ..The aim of this study was to investigate the response rate and progression-free survival in a series of epithelioid sarcoma patients treated with chemotherapy at a single referral center...
  5. doi request reprint Advanced aggressive fibromatosis: Effective palliation with chemotherapy
    Anastasia Constantinidou
    Sarcoma Unit, Royal Marsden Hospital, London, United Kingdom
    Acta Oncol 50:455-61. 2011
    ..Aggressive fibromatosis (AF) is a locally invasive proliferative disease. The mainstay of treatment is surgery. Chemotherapy may be considered in inoperable AF following failure of hormonal therapy and/or NSAIDs...
  6. doi request reprint The evolution of systemic therapy in sarcoma
    Anastasia Constantinidou
    The Royal Marsden Hospital, London, UK
    Expert Rev Anticancer Ther 13:211-23. 2013
    ..Some histological subtypes are resistant to conventional chemotherapy and patients with these diseases should be offered participation in early phase clinical trials of novel drugs...
  7. ncbi request reprint Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection
    Anastasia Constantinidou
    Department of Medicine, Royal Marsden Hospital, London and Surrey, UK
    Clin Colorectal Cancer 12:15-22. 2013
    ..A retrospective review of our patient records showed that the addition of bevacizumab did not increase morbidity or mortality related to liver resection. Pathologic complete response (CR) is associated with prolonged survival...
  8. doi request reprint Chemotherapy in clear cell sarcoma
    Robin L Jones
    Royal Marsden Hospital, London, UK
    Med Oncol 28:859-63. 2011
    ..These data provide a reference for response and outcome in the assessment of novel agents in this histological subtype...
  9. doi request reprint Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?
    Anastasia Constantinidou
    Breast Unit, Royal Marsden Hospital, London UK and Institute of Cancer Research, London, UK
    Breast 20:S158-61. 2011
    ..Meanwhile there is already enough circumstantial evidence to justify anti-HER2 therapy alone in selected patients for whom chemotherapy is contraindicated...
  10. ncbi request reprint Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience
    Michael S Hofman
    PET Imaging Centre at St Thomas, Guy s and St Thomas Foundation NHS Trust, and King s College, London, UK
    Nucl Med Commun 28:902-6. 2007
    ..This study evaluates our early experience in the use of FDG PET-CT in the assessment of early response to chemotherapy in metastatic melanoma...
  11. doi request reprint Beyond triple-negative breast cancer: the need to define new subtypes
    Anastasia Constantinidou
    Royal Marsden Hospital, London, UK
    Expert Rev Anticancer Ther 10:1197-213. 2010
    ..Understanding the molecular underpinning of distinct subgroups of these cancers is crucial for the identification of novel therapeutic targets and individualization of treatment for patients with triple-negative disease...